Merck news
Merck appears in 2 stories we have published between August 2026 and October 2026, mostly in our Technology coverage. It is most often reported alongside Moderna, Amazon and BookMyShow.
Latest development
Merck and Moderna’s mRNA cancer vaccine cuts melanoma recurrence by 42% in Phase III trial
Merck and Moderna have released Phase III trial results for their personalized mRNA cancer vaccine, intismeran autogene, showing a 42% reduction in melanoma recurrence or death when combined with Keytruda. The vaccine also improved cancer-free survival rates, marking a milestone for mRNA-based cancer treatments.
24 October 2026
Covered alongside
Merck and Moderna’s mRNA cancer vaccine cuts melanoma recurrence by 42% in Phase III trial
Merck and Moderna’s personalized mRNA cancer vaccine, intismeran autogene, reduced melanoma recurrence by 42% and improved cancer-free survival rates…
Nikhil Kamath invests Rs 200 crore in CtrlS Datacentres
Zerodha co-founder Nikhil Kamath invests Rs 200 crore in CtrlS Datacentres, boosting India’s data centre capacity amid rising demand for digital infrastructure.